癌的社会经济差异:对治疗延迟和生存的影响
Pramod Nepal1, Muhammad H Zafar1, Li C Liu2
1Division of Colon and Rectal Surgery, University of Illinois at Chicago, Chicago, Illinois.
Diseases of the colon and rectum
|February 27, 2024
概括
较低的社会经济地位与治疗延迟和部平细胞癌患者的生存率较差有关. 解决这些差异对于改善护理准入和结果至关重要.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 社会经济不平等严重影响医疗保健的获取,可能导致癌症治疗和生存结果的差异.
- 了解这些差异对于开发有针对性的干预措施来提高癌症护理公平性至关重要.
研究的目的:
- 检查社会经济因素对 squamous-cell carcinoma (ASCC) 治疗开始时间的影响.
- 研究ASCC患者的社会经济地位和整体生存率之间的关联.
主要方法:
- 来自国家癌症数据库 (2004-2016) 的全国数据集的回顾性分析.
- 包括被诊断患有I-III期ASCC的患者,接受化学辐射治疗.
- 评估社会经济因素,包括收入,教育水平和保险状况.
主要成果:
- 分析了24143名ASCC患者的队列;中位数年龄为60岁,其中70%为女性.
- 来自低收入地区,教育程度较低或接受公共保险 (Medicaid) 的患者经历了超过60天的治疗延迟.
- 卡普兰-梅尔分析显示,与即时治疗 (125个月;p < 0.001) 相比,延迟治疗的患者的整体存活率 (98个月) 显着较差.
结论:
- 较低的社会经济地位,以收入,教育和保险类型来表示,与ASCC治疗的时间延长有关.
- 由于社会经济因素而延迟治疗与ASCC患者的整体存活率降低有关.
- 这些发现强调了需要采取干预措施来缓解社会经济差异,并改善及时获得癌症护理的机会.
相关概念视频
01:21Cancer Survival Analysis
346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346
01:20Comparing the Survival Analysis of Two or More Groups
186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
01:20Actuarial Approach
78
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
78
01:25Statistical Methods for Analyzing Epidemiological Data
366
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
366
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K